Table 1 Tumor clinico-pathological features, cytology, and RNA yields of the patients.
Patient No. | Tumor Type | Tumor Size (cm) | Tumor Grade | ER* | PR* | HER2* | Positive Nodes | PRE Total RNA (μg) | PRE Tumor Cell (%) | POST Total RNA (μg) | POST Tumor Cell (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IDC | 2.8/2.6 | 2 & 3 | + | + | + | 2–26 | 9.6 | >99 | 15.4 | >99 |
2 | IDC | 1.9 | 3 | + | + | - | 0/12 | 0.8 | >99 | 1.4 | >99 |
3 | IDC | 2 | 3 | + | + | - | 1–17 | 0.4 | >99 | 9.8 | >99 |
4 | IDC | 1.6 | 3 | + | + | - | 1–4 | 1.9 | >99 | 1.4 | >99 |
5 | IDC | 3 | 2 | + | - | - | 0/16 | 0.2 | >99 | 1 | ** |
6 | IDC | 15 | 3 | + | + | - | 29/32 | 0.5 | >99 | 1.8 | >99 |
7 | IDC | 4.5 | 3 | - | - | + | 0/11 | 7.6 | >99 | 30.4 | >99 |
8 | IDC | 1.6 | 2 | + | + | - | 0/16 | 1.4 | >99 | 3.7 | >99 |
9 | IDC | 1.7 | 3 | - | - | - | 1–18 | 2 | >99 | 1.1 | >99 |
10 | IDC | 2.2/1.0 | 3 | - | - | + | 2–17 | 7.5 | >99 | 3.4 | >99 |
11 | IDC/lobular | 6.5 | 2 | + | + | - | 8–15 | 1.5 | >99 | 3.2 | >99 |
12 | IDC | 2.5 | 3 | - | - | - | 8–25 | 1.3 | ** | 12.4 | >99 |
13 | IDC | 4 | 2 | + | + | - | 2–20 | 4.2 | >99 | 8.5 | >99 |
14 | IDC | 6.5 | 2 | - | - | + | 1–12 | 9.5 | >99 | 3.2 | >99 |
15 | IDC | 2.1 | 2 | + | + | - | 0/3 | 1.2 | >99 | 9.6 | 50 |
16 | IDC | 3.4 | 2 | + | + | - | 0/3 | 1.9 | >99 | 0.4 | >99 |